Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

798 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure.
Køber L, Thune JJ, Nielsen JC, Haarbo J, Videbæk L, Korup E, Jensen G, Hildebrandt P, Steffensen FH, Bruun NE, Eiskjær H, Brandes A, Thøgersen AM, Gustafsson F, Egstrup K, Videbæk R, Hassager C, Svendsen JH, Høfsten DE, Torp-Pedersen C, Pehrson S; DANISH Investigators. Køber L, et al. N Engl J Med. 2016 Sep 29;375(13):1221-30. doi: 10.1056/NEJMoa1608029. Epub 2016 Aug 27. N Engl J Med. 2016. PMID: 27571011 Free article. Clinical Trial.
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.
Hernandez AF, Green JB, Janmohamed S, D'Agostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S; Harmony Outcomes committees and investigators. Hernandez AF, et al. Lancet. 2018 Oct 27;392(10157):1519-1529. doi: 10.1016/S0140-6736(18)32261-X. Epub 2018 Oct 2. Lancet. 2018. PMID: 30291013 Free article. Clinical Trial.
Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction-Results of the CHIARA MIA 1 Trial.
Düngen HD, Kober L, Nodari S, Schou M, Otto C, Becka M, Kanefendt F, Winkelmann BR, Gislason G, Richard F, Nielsen OW, Gheorghiade M, Senni M. Düngen HD, et al. Among authors: schou m. Clin Pharmacol Drug Dev. 2019 Oct;8(7):942-951. doi: 10.1002/cpdd.633. Epub 2018 Nov 19. Clin Pharmacol Drug Dev. 2019. PMID: 30452784 Clinical Trial.
Incidence of atrial fibrillation in conjunction with breast cancer.
D'Souza M, Smedegaard L, Madelaire C, Nielsen D, Torp-Pedersen C, Gislason G, Schou M, Fosbøl E. D'Souza M, et al. Among authors: schou m. Heart Rhythm. 2019 Mar;16(3):343-348. doi: 10.1016/j.hrthm.2018.10.017. Epub 2019 Jan 29. Heart Rhythm. 2019. PMID: 30709772
Polygenic predisposition to breast cancer and the risk of coronary artery disease.
D'Souza M, Schou M, Skals R, Weeke PE, Lee C, Smedegaard L, Madelaire C, Gerds TA, Poulsen HE, Hansen T, Grarup N, Pedersen O, Stender S, Engstrøm T, Fosbøl E, Nielsen D, Gislason G, Køber L, Torp-Pedersen C, Andersson C. D'Souza M, et al. Among authors: schou m. Int J Cardiol. 2019 Sep 15;291:145-151. doi: 10.1016/j.ijcard.2019.05.051. Epub 2019 May 24. Int J Cardiol. 2019. PMID: 31155334
798 results